生命线饮食得分和GDM之间的关联:一个病例对照研究
Mohammad Othman Abudari1, Nahlah Fahad Alreshidi2, Saud Salman Alharbi3
1Community Health Nursing Department, School of Nursing, The University of Jordan, Aqaba, Jordan.
Frontiers in nutrition
|August 14, 2025
概括
对生命线饮食评分 (LLDS) 的更高遵守与妊娠糖尿病 (GDM) 的几率显著降低有关. 这表明,整体饮食质量可能在怀孕期间预防GDM中发挥关键作用.
科学领域:
- 产科和妇科 产科和妇科
- 营养科学 营养科学
- 流行病学 流行病学
背景情况:
- 孕期糖尿病 (GDM) 是一种普遍存在的妊娠并发症,对母亲和孩子的健康有严重影响.
- 饮食因素与GDM发展有关,但整体饮食质量指数的作用,如生命线饮食评分 (LLDS) 并未得到充分确立.
研究的目的:
- 调查遵守生命线饮食得分 (LLDS) 与患妊娠糖尿病 (GDM) 的可能性之间的关联.
主要方法:
- 进行了一项病例控制研究,涉及150例GDM病例和150个匹配的对照.
- 生命线饮食得分 (LLDS) 计算使用半定量食物频率问卷来评估饮食摄入量.
- 采用多变量逻辑回归来分析LLDS和GDM几率之间的关系.
主要成果:
- 较高的LLDS四分位数与更健康的饮食模式相关,包括增加水果,蔬菜和豆类的摄入量,减少红色/加工肉类和含糖饮料的摄入量.
- 与最低四分位数的参与者相比,LLDS四分位数最高的参与者对GDM的几率明显较低 (调整后OR:0.23;P趋势<0.001).
结论:
- 对LLDS的更强的坚持与妊娠糖尿病的几率降低有关.
- 这些发现强调了整体饮食质量在怀孕期间对母亲代谢健康的潜在重要性.
- 需要进一步的研究,包括前性和干预性研究,以确认这些关联并了解相关机制.
更多相关视频
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications
692
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
692
Dipeptidyl Peptidase 4 Inhibitors
257
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
257
Oral Hypoglycemic Agents: Biguanides and Glitazones
296
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
296
Hypoglycemia and Glucagon
335
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
335


